Lyell Immunopharma (LYEL) Return on Sales (QoQ) (2020 - 2026)
Lyell Immunopharma (LYEL) Return on Sales (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Lyell Immunopharma | 276.08 Mn | 276.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27,493.00 |
| Dec 31, 2025 | -17,304.00 |
| Sep 30, 2025 | 7,622.00 |
| Jun 30, 2025 | 3,978.00 |
| Mar 31, 2025 | 32,593.00 |
| Dec 31, 2024 | -47,346.00 |
| Sep 30, 2024 | 6,301.00 |
| Jun 30, 2024 | 15,010.00 |
| Mar 31, 2024 | -1,367.00 |
| Dec 31, 2023 | -20,801.00 |
| Sep 30, 2023 | 561.00 |
| Jun 30, 2023 | -2,082.00 |
| Mar 31, 2023 | -1,278.00 |
| Dec 31, 2022 | 62,789.00 |
| Sep 30, 2022 | -62,789.00 |
| Jun 30, 2022 | 313.00 |
| Mar 31, 2022 | -255.00 |
| Dec 31, 2021 | -40.00 |
| Sep 30, 2021 | 44.00 |
| Jun 30, 2021 | -43.00 |